Skip to main content

Vascepa News

FDA Approves Vascepa (icosapent ethyl) to Reduce Cardiovascular Risk

DUBLIN, Ireland and BRIDGEWATER, N.J., Dec. 13, 2019 (GLOBE NEWSWIRE) – Amarin Corporation plc (NASDAQ: AMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved a new...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Cardiovascular Risk Reduction

Vascepa patient information at Drugs.com